Koyfin Home > Directory > Health Care > Kezar Life Sciences Inc > Total Debt / Equity

Kezar Life Sciences Inc Total Debt / Equity Chart (KZR)

Kezar Life Sciences Inc annual/quarterly Total Debt / Equity from 2019 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Kezar Life Sciences Inc Total Debt / Equity for the quarter ending June 06, 2020 was $4m a -102.73% decrease of -4m year over year
  • Kezar Life Sciences Inc Total Debt / Equity for the last 12 months ending June 06, 2020 was $4m a -102.73% decrease of -4m year over year
Other Ratios Metrics:
  • Kezar Life Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $3m
View Chart On Koyfin

Quarterly KZR Total Debt / Equity Data

06/2020$4m
03/2020$5m
12/2019$8m
09/2019$8m
06/2019$7m
03/2019$7m

Annual KZR Total Debt / Equity Data

2019$8m